A new treatment for severe emphysema using heat and liquid
Part of Lungs & breathing clinical trials.
This trial tests a procedure called Endobronchial Thermal Liquid Ablation (ETLA) that uses heated liquid to treat severe emphysema. It is for people with COPD who have very low lung function and shortness of breath, and who have not been able to get relief from other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 years or older
- You must have a diagnosis of COPD with severe lung function (FEV1 between 20% and 49% of predicted)
- You must have had trouble breathing for at least 3 months and be on stable medications
- You must have walked at least 140 meters in 6 minutes
- You must have been smoke-free for at least 3 months
- You must be willing to stay near the hospital for at least 5 days after the procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with uneven emphysema to better understand outcomes and safety after treatment. If you qualify, you’ll share health information and may undergo lung imaging before and after treatment.
This study tests a bronchoscopic treatment that uses radiofrequency energy to reduce COPD symptoms. It may help people who still have breathing problems despite taking medication.
This study compares two minimally invasive treatments—bronchoscopic thermal vapor ablation (BTVA) and microwave ablation (MWA)—for people with COPD and early-stage lung cancer. Both treatments aim to destroy cancer cells without surgery, which may be a good option if you cannot or prefer not to have surgery.
This study tests a new treatment that uses brief electric pulses to clear blocked airways in people with chronic bronchitis. It might help if you have a long-term cough with mucus and standard medicines aren't enough.
This study tests a bronchoscopic treatment to release trapped air in severely hyperinflated lungs caused by emphysema. It may help you breathe easier if you have advanced COPD and meet specific lung function and imaging criteria.
This trial tests an implantable artificial bronchus to help people with severe emphysema breathe easier. It's for those who have stable COPD, can walk 100–400 meters in 6 minutes, and haven't smoked for at least 4 months.
Hear when a new Emphysema or COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.